<DOC>
	<DOCNO>NCT02169869</DOCNO>
	<brief_summary>The study randomize clinical trial . Women le 10 prenatal visit and/or 2 show visit desire Intrauterine Device ( IUD ) consider enrollment . If consent meet inclusion criterion , randomize delivery receive IUD immediately postplacental routine postpartum visit . Women plan deliver live birth singleton via vaginal cesarean delivery Oregon Health Science University ( OHSU ) hospital consider inclusion study . Women desire IUD postpartum contraception approach study participation . The postpartum contraception plan routinely documented prenatal course . It also address obstetrical team upon admission Labor &amp; Delivery OHSU . The obstetrical team identify subject present labor meet criterion poor prenatal clinic attendance express interest intrauterine contraception . Immediately vaginal cesarean delivery , consent subject randomize immediate postplacental IUD placement IUD placement routine postpartum visit . Women randomize immediate postplacental IUD group receive IUD within 60 minute placental delivery . Prior discharge hospital woman receive postplacental IUD assist schedule routine postpartum visit primary provider . Subjects randomize IUD insertion postpartum visit assist schedule postpartum visit IUD placement usual obstetrical care provider . All subject delay group provide contact information Women 's Health Research Unit ( WHRU ) OHSU . If subject obtain IUD usual place care , device place cost WHRU . At 3 month delivery , subject contact phone , text , email complete questionnaire determine whether know expulsion , pregnancy , elective IUD removal . The questionnaire include question regard ease placement overall satisfaction timing placement . Subjects compensate participation study 3 month contact .</brief_summary>
	<brief_title>Immediate Postplacental IUD Insertion</brief_title>
	<detailed_description />
	<mesh_term>Copper</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<criteria>Female 18 yo old Singleton pregnancy â‰¥32 week gestation time enrollment Voluntarily request either copper T380A levonorgestrel IUD ( LNGIUS ) placement postpartum contraception English Spanish speak Able give consent agree term study Less 10 prenatal visit 2 show visit Since IUDs hospital formulary , patient must qualify Long Acting Reversible Contraceptive ( LARC ) IUD ( include Oregon Health Plan ( OHP ) Citizen/Alien Waived Emergent Medical ( CAWEM ) insure patient woman income &lt; 300 % federal poverty line ) . Anatomic uterine abnormality prevent proper fundal placement IUD ( obstructive myoma , bicornuate , septate , etc ) Chorioamnionitis ( also consider risk factor prolong rupture membrane &gt; 18 hour , prolong labor &gt; 24 hour , fever &gt; 38C ) Puerperal sepsis Unresolved postpartum hemorrhage Extensive genital trauma Current incarceration Known suspect untreated endocervical gonorrhea , chlamydia Wilson 's disease , copper allergy ( Paragard ) Known suspect cervical endometrial cancer pelvic tuberculosis Current breast cancer ( LNGIUS ) Systemic lupus erythematosus ( SLE ) severe thrombocytopenia ( Paragard ) Trophoblastic disease ( benign malignant ) AIDS stable antiretroviral</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>intrauterine device , postpartum , contraception , Mirena , Paragard , intrauterine system</keyword>
</DOC>